Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04821960 · ClinicalTrials.gov registry record · NA
Memory and Fear Study (Fear of Memory Loss Study)
A NA study, sponsored by Northwestern University.
- Completed
- Registry status
- NA
- Development phase
- 81
- Enrollment target
NCT04821960: Completed NA study, sponsored by Northwestern University.
NCT04821960 is a NA study that has completed, run by Northwestern University. The registered enrollment target is 81 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04821960, a NA study, has completed, sponsored by Northwestern University.
- COMPLETED
- Registry status
- NA
- Development phase
- 81 participants
- Enrollment target
Study Summary
This study is a randomized control study to determine the impact of a tailored, web-based mindfulness program to reduce anxiety and increase the quality of life in older adults experiencing dementia-related fears, relative to a conventional meditation program.
Primary Outcome
A 24-item scale to assess fear of memory loss. Scores range from 24-120 points with a higher score indicating a higher fear of memory loss.
Interventions
- BEHAVIORAL Tailored Mindfulness Program for Fear of Memory Loss
- BEHAVIORAL Conventional Mindfulness Program
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 81 participants |
| Start Date | 2021-05-17 |
| Est. Completion | 2022-12-31 |
| Phase | NA |
What the finished NCT04821960 record still lists
NCT04821960 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 81 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which Tailored Mindfulness Program for Fear of Memory Loss is the first listed.
NCT04821960 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04821960 about?
NCT04821960 is a clinical study titled "Memory and Fear Study (Fear of Memory Loss Study)". This study is a randomized control study to determine the impact of a tailored, web-based mindfulness program to reduce anxiety and increase the quality of life in older adults experiencing dementia-related fears, relative to a conventional meditation program.
What is the current status of trial NCT04821960?
This trial is currently completed. It is a NA study. The enrollment target is 81 participants. The study started on 2021-05-17. Estimated completion is 2022-12-31.
What interventions are being tested in trial NCT04821960?
The interventions under investigation include: Tailored Mindfulness Program for Fear of Memory Loss (BEHAVIORAL), Conventional Mindfulness Program (BEHAVIORAL).
Who is sponsoring clinical trial NCT04821960?
This trial is sponsored by Northwestern University, which has 1,209 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04821960's enrollment target sits among peer trials
81 992nd of 2000 higher than 1,007 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04966481 · 81 participants · Phase 3
Palbociclib and Cetuximab Versus Cetuximab Monotherapy for Patients With CDKN2A-altered, HPV-unrelated Head and Neck Squamous Cell Carcinoma Who Experienced Disease Progression on a PD-1/L1 Inhibitor
- NCT05109429 · 81 participants · NA
Developing a Clinical Outcome Assessment for Opioid Craving
- NCT05112601 · 81 participants · Phase 2
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
- NCT05305911 · 81 participants · Phase 2
Sodium Glucose Co-Transporter 2 (SGLT2) and STEMI
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI